Skip to main content

SpO2

0
Pipeline Programs
3
Companies
5
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Philips
PhilipsNetherlands - Amsterdam
2 programs
Alar SpO2 Sensor StudyN/A1 trial
SaO2 SamplingN/A1 trial
Active Trials
NCT06398262Completed56Est. Nov 2025
NCT06372106Recruiting560Est. Dec 2025
Masimo
MasimoIRVINE, CA
2 programs
Masimo INVSENSOR00061N/A1 trial
Masimo SensorN/A1 trial
Active Trials
NCT05896267Completed64Est. Jun 2023
NCT07223177Recruiting100Est. Jun 2026
GE HealthCare
1 program
SpO2 Sensor TestingN/A1 trial
Active Trials
NCT06211530Completed32Est. Feb 2024

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
MasimoMasimo Sensor
PhilipsAlar SpO2 Sensor Study
PhilipsSaO2 Sampling
GE HealthCareSpO2 Sensor Testing
MasimoMasimo INVSENSOR00061

Clinical Trials (5)

Total enrollment: 812 patients across 5 trials

NCT07223177MasimoMasimo Sensor

Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations

Start: Dec 2025Est. completion: Jun 2026100 patients
N/ARecruiting
NCT06398262PhilipsAlar SpO2 Sensor Study

Alar SpO2 Sensor Study

Start: Sep 2024Est. completion: Nov 202556 patients
N/ACompleted
NCT06372106PhilipsSaO2 Sampling

Project Mountain - Comparing SpO2 and SaO2 for Accuracy

Start: Apr 2024Est. completion: Dec 2025560 patients
N/ARecruiting
NCT06211530GE HealthCareSpO2 Sensor Testing

Wireless Disposable SpO2 Sensor Hypoxia Testing

Start: Jan 2024Est. completion: Feb 202432 patients
N/ACompleted
NCT05896267MasimoMasimo INVSENSOR00061

SpO2 Data Collection in Pediatric Patients Using INVSENSOR00061

Start: May 2023Est. completion: Jun 202364 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 812 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.